OPRX Stock — OPTIMIZERx Corp

OPTIMIZERx Corp (OPRX)

Updated October 16, 2026.

OPRX is a Stock. Its deepest 1-year drawdown was 79.1%.

OptimizeRx Corporation is a digital healthcare technology company that provides software platforms and media solutions for pharmaceutical marketing and patient engagement. Its offerings include audience targeting and analytics tools, prescription and copay messaging for healthcare providers, pharmacy alerts, and programmatic advertising delivery across multiple channels including digital, television, and social media. The company does not currently distribute dividends and is oriented toward growth-focused investors rather than income seekers.

OPRX performance

Returns are updating. OPRX's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 79.1%.

OPRX key facts

Asset type

Stock

Asset class

Equity

Inception date

05/18/2005

Distribution frequency

None

Last close

$8.50 (as of 2026-10-16)

Market cap

$160,105,584

Average volume

101176.0

Payment date

05/14/2018

Beta

1.26

Payout ratio

0.0%

P/E ratio

35.42

Forward P/E

5.6306

EPS

$0.24

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

OPRX risks and drawbacks

The deepest 1-year drawdown on record here is 79.1%.

Who may consider OPRX — and who may not

It is a weaker fit for investors who need monthly cash flow (OPRX does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on OPRX

• All tickers starting with O

Tagged: Healthcare.

Frequently asked questions